MedTrace Logo

Evaluation of the Cryopreserved Amniotic Membranes in the Care of Resistant Vascular Ulcers

NCT00820274 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2015-09-01

No results posted yet for this study

Summary

To evaluate tolerance and efficiency of cryopreserved amniotic membranes in local treatment of resistant vascular ulcers.

To evaluate complete cicatrisation, efficiency on pain, prevention of infection, improvement of quality of life.

To evaluate rate of amputations and recurrence at one year after complete cicatrisation

Conditions

  • Resistant Vascular Ulcers

Interventions

PROCEDURE

amniotic membranes

The amniotic membrane is taken with a sterile crowbar then applied side foetal face against the ulcer and displayed in a homogeneous way

Sponsors & Collaborators

  • Etablissement Français du Sang

    collaborator OTHER

  • University Hospital, Limoges

    lead OTHER

Principal Investigators

  • Francis Pesteil, MD · CHU Limoges

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2013-12-31
Completion
2016-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00820274 on ClinicalTrials.gov